Clinical Trial Update: Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia [Phase 4]

View source ↗

Summary

Phase 4 trial update on azilsartan medoxomil for essential hypertension and type 2 diabetes mellitus completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Azilsartan medoxomil (azilsartan medoxomil)

Snippet

Sponsor: Takeda | Conditions: Essential Hypertension, Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2019-03-01